EMY explainer covers how long GLP-1 drugs have been on the market
A basic overview of GLP-1 drugs, their uses and safety. Evergreen background with no new developments.
Recap by typeshit. Full story at EMY.
Read at EMY
More peptides
-
JB Pritzker says he lost 80 pounds in two years on GLP-1 drugs 
JB Pritzker says he lost 80 pounds in two years on GLP-1 drugs
The Illinois governor is speaking openly about his own GLP-1 use, saying he wants to end the stigma around the drugs. The post comes from a political fan page on Facebook.
-
Alice Trell says Ozempic and peptides won't build lower body muscle 
Alice Trell says Ozempic and peptides won't build lower body muscle
Trell argues a toned lower body comes from lean muscle, crediting weekly strength training and recovery fuel rather than Ozempic or peptides.
-
Novo Nordisk faces a lost ad injunction, CagriSema data and a pediatric approval 
Novo Nordisk faces a lost ad injunction, CagriSema data and a pediatric approval
The FDA cleared Awiqli as the first weekly insulin for kids 10 and up with type 2 diabetes, and a CagriSema subgroup showed 25% weight loss in women.
-
Philstar Life explains how oral Wegovy is made and where it's available Philstar Life explains how oral Wegovy is made and where it's available
A rundown on the pill version of Wegovy, covering what form it comes in and its availability. Thin on details, so tap through for the specifics.
-
General Medicine CEO TJ Parker says insurers hide cheaper GLP-1 options from patients peptides typeshitPricesGeneral Medicine CEO TJ Parker says insurers hide cheaper GLP-1 options from patients
Parker argues patients can spend two weeks fighting for coverage of one GLP-1 without learning another brand might cost them nothing.
-
Cardiologist Chayakrit Krittanawong asks what trials show on GLP-1s and kidney health peptides typeshitResearchCardiologist Chayakrit Krittanawong asks what trials show on GLP-1s and kidney health
Part of his GLP-1 series, Krittanawong looks at research suggesting these drugs may protect the kidneys beyond blood sugar and weight.
